GlaxoSmithKline named Philip Hampton as its next chairman as the pharmaceuticals giant struggles to right itself amid a series of probes over alleged overseas bribery.
via WSJ.com: US Business http://ift.tt/1vhuJXk
via WSJ.com: US Business http://ift.tt/1vhuJXk
Nessun commento:
Posta un commento